Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Mol Biosyst. 2015 Sep;11(9):2406–2416. doi: 10.1039/c5mb00237k

Table 2. Pathways enriched for metabolic changes in MQ-treated Jurkat cells compared to chemotherapeutic-treated Jurkat cells.

Metabolites contributing to the significance of each pathway, along with their fold change across all time points, are included in Table S5.

Pathway FDR-corrected p-value
Propanoate metabolism 0.000257
Pyrimidine metabolism 0.000257
beta-Alanine metabolism 0.000257
Pantothenate and CoA biosynthesis 0.000257
Glycerophospholipid metabolism 0.000649
Sphingolipid metabolism 0.002883
Pentose phosphate pathway 0.00919
Alanine, aspartate and glutamate metabolism 0.029828
Glyoxylate and dicarboxylate metabolism 0.029828
Butanoate metabolism 0.030357
Arginine and proline metabolism 0.030357
Pentose and glucuronate interconversions 0.030357